HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1424721Generated: October 30, 2026
Boron tribromide → 4-(3-p-Tolyl-[1,2,4]triazol-1-yl)-phenol
https://huagongshe.com/reaction/1424721
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Boron tribromide | HCID 25134 | — |
| Reactant | 4-Iodoanisole | HCID 69676 | — |
| Reactant | 1-(4-Methoxyphenyl)-3-p-tolyl-1H-[1,2,4]triazole | HCID 67519180 | — |
| Reactant | HCID 178423994 | HCID 178423994 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | 1-(4-Methoxyphenyl)-3-p-tolyl-1H-[1,2,4]triazole | HCID 67519180 | — |
| Product | 4-(3-p-Tolyl-[1,2,4]triazol-1-yl)-phenol | HCID 67519505 | 136.3% |
Reaction Steps
1-(4-Methoxyphenyl)-3-p-tolyl-1H-[1,2,4]triazole was prepared by coupling 3-p-tolyl-1H-[1,2,4]triazole with 4-iodoanisole under conditions described in Step 1 of the previous example. This material was then demethylated using conditions described in Hitchcock et al. Synlett 2006, 2625. Boron tribromide (1 M solution in hexanes; 1.67 mL, 1.67 mmol) was added dropwise to a solution of 1-(4-methoxyphenyl)-3-p-tolyl-1H-[1,2,4]triazole (300 mg, 1.28 mmol) in CH2Cl2 (10 mL) at 0° C. under N2. After addition was complete, the vessel was warmed to ambient temperature before refluxing at 40° C. for 6 h. The cooled contents were then quenched with H2O before removal of the CH2Cl2 and partitioning between EtOAc and water. The organic layer was collected, washed with brine, dried (MgSO4), concentrated, and purified via chromatography (3:1:1, hexanes:EtOAc:acetone) to afford the 4-(3-p-tolyl-[1,2,4]triazol-1-yl)-phenol intermediate (219 mg, 0.872 mmol, 68%). Trifluoromethanesulfonic anhydride (0.16 mL, 0.96 mmol) was added dropwise to a solution of the phenol and 4-tert-butyl-2,6-dimethylpyridine (142 mg, 0.872 mmol) in CH2Cl2 (10 mL) at 0° C. under N2. The vessel was warmed to ambient temperature before the solvent was removed under reduced pressure and the residue purified via chromatography (2:2:1, hexanes:EtOAc:acetone) affording the trifluoromethanesulfonic acid 4-(3-p-tolyl-[1,2,4]triazol-1-yl)-phenyl ester intermediate (304 mg, 0.794 mmol, 91%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08927729B2 |
|---|
| Source dataset | uspto-grants-2015_01 |
|---|
| ORD ID | ord-fafa3174c3b44136b38b49858c50d1ff |
|---|
| Source note | uspto-grants-2015_01 |
|---|